SCHEMBL6727945

SCHEMBL6727945

CC(N)(CO)CCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11497955 0.83
SCHEMBL1276009 0.81
SCHEMBL1132514 0.79
Ammonia Solution, Strong SCHEMBL23589353 0.78 CYP2D6 (0.33)
SCHEMBL23687 0.77
SCHEMBL1926590 0.77
SCHEMBL7708258 0.77
SCHEMBL1170269 0.77
Hydrochloric Acid SCHEMBL9779092 0.77
SCHEMBL5397979 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6387399-B1 Microencapsulated bioactive agents and method of making THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION 2002-05-14 US claimed
US-20010026812-A1 Method for determining the three-dimensional structure of a protein GOVERNMENT OF THE UNITED STATES OF AMERICA, NATIONAL AERONAUTICS & SPACE ADMINISTRATION 2001-10-04 US claimed
US-20010006679-A1 X-ray crystallography reagent NATIONAL AERONAUTICS & SPACE ADMINISTRATION 2001-07-05 US claimed
US-20010002261-A1 Microencapsulated bioactive agents and method of making GOVERNMENT OF THE UNITED STATES OF AMERICA NATIONAL AERONAUTICS & SPACE ADMINISTRATION 2001-05-31 US claimed
US-11179389-B2 Purine inhibitors of human phosphatidylinositol 3-kinase delta MERCK SHARP & DOHME CORP. (US) 2021-11-23 US disclosed
US-20200390760-A1 PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA MERCK SHARP & DOHME CORP. (US) 2020-12-17 US disclosed
US-6676964-B2 MICROCAPSULES MADE BY ENCAPSULATION OF PROTEIN, DRUG, OR OTHER BIOACTIVE SUBSTANCE INSIDE POLYMERIC SEMIPERMEABLE MEMBRANE; INTERFACIAL COACERVATION, SATURATION, NUCLEATION, CRYSTALLIZATION; STORAGE STABILITY; THE UNITED STATES OF AMERICA AS REPRESENTED BY THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION 2004-01-13 US disclosed
US-6599449-B2 X-ray crystallography reagent THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION 2003-07-29 US disclosed
US-6558698-B2 Microcapsule containing solutons and/or crystals of biactive drugs or proteins, that have a semipermeable membrane which are rugged enough to protect fragile crystal and resist shear and other mechanical forces associated with handling THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION 2003-05-06 US disclosed
US-6387399-B1 Microencapsulated bioactive agents and method of making THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION 2002-05-14 US disclosed
US-20010026812-A1 Method for determining the three-dimensional structure of a protein GOVERNMENT OF THE UNITED STATES OF AMERICA, NATIONAL AERONAUTICS & SPACE ADMINISTRATION 2001-10-04 US disclosed
US-20010006679-A1 X-ray crystallography reagent NATIONAL AERONAUTICS & SPACE ADMINISTRATION 2001-07-05 US disclosed
US-20010002261-A1 Microencapsulated bioactive agents and method of making GOVERNMENT OF THE UNITED STATES OF AMERICA NATIONAL AERONAUTICS & SPACE ADMINISTRATION 2001-05-31 US disclosed